▶ 調査レポート

世界の肺がん液体バイオプ市場：市場規模・現状・予測
• 英文タイトル：Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の肺がん液体バイオプ市場：市場規模・現状・予測 / Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2019-2025 / QYR9N7485資料のイメージです。• レポートコード：QYR9N7485
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、肺がん液体バイオプのグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・肺がん液体バイオプの世界市場規模
・主要企業別市場シェア
・肺がん液体バイオプの世界市場規模：種類別（）
・肺がん液体バイオプの世界市場規模：用途別（）
・肺がん液体バイオプのアメリカ市場規模（種類別、用途別）
・肺がん液体バイオプのヨーロッパ市場規模（種類別、用途別）
・肺がん液体バイオプの中国市場規模（種類別、用途別）
・肺がん液体バイオプの日本市場規模（種類別、用途別）
・肺がん液体バイオプの東南アジア市場規模（種類別、用途別）
・肺がん液体バイオプのインド市場規模（種類別、用途別）
・肺がん液体バイオプの中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・肺がん液体バイオプの世界市場予測（2019年-2025年）
・肺がん液体バイオプの地域別市場予測（2019年-2025年）
...

In 2018, the global Lung Cancer Liquid Biops market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Lung Cancer Liquid Biops status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Liquid Biops development in United States, Europe and China.

The key players covered in this study
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine

Market segment by Type, the product can be split into
Exosomes and RNA
CTCs and ctDNA

Market segment by Application, split into
Hospitals and Clinics
Physicians’office Laboratories
Clinical Diagnostic Laboratories

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lung Cancer Liquid Biops status, future forecast, growth opportunity, key market and key players.
To present the Lung Cancer Liquid Biops development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lung Cancer Liquid Biops are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type (2014-2025)
1.4.2 Exosomes and RNA
1.4.3 CTCs and ctDNA
1.5 Market by Application
1.5.1 Global Lung Cancer Liquid Biops Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Physicians’office Laboratories
1.5.4 Clinical Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lung Cancer Liquid Biops Market Size
2.2 Lung Cancer Liquid Biops Growth Trends by Regions
2.2.1 Lung Cancer Liquid Biops Market Size by Regions (2014-2025)
2.2.2 Lung Cancer Liquid Biops Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lung Cancer Liquid Biops Market Size by Manufacturers
3.1.1 Global Lung Cancer Liquid Biops Revenue by Manufacturers (2014-2019)
3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)
3.2 Lung Cancer Liquid Biops Key Players Head office and Area Served
3.3 Key Players Lung Cancer Liquid Biops Product/Solution/Service
3.4 Date of Enter into Lung Cancer Liquid Biops Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lung Cancer Liquid Biops Market Size by Type (2014-2019)
4.2 Global Lung Cancer Liquid Biops Market Size by Application (2014-2019)

5 United States
5.1 United States Lung Cancer Liquid Biops Market Size (2014-2019)
5.2 Lung Cancer Liquid Biops Key Players in United States
5.3 United States Lung Cancer Liquid Biops Market Size by Type
5.4 United States Lung Cancer Liquid Biops Market Size by Application

6 Europe
6.1 Europe Lung Cancer Liquid Biops Market Size (2014-2019)
6.2 Lung Cancer Liquid Biops Key Players in Europe
6.3 Europe Lung Cancer Liquid Biops Market Size by Type
6.4 Europe Lung Cancer Liquid Biops Market Size by Application

7 China
7.1 China Lung Cancer Liquid Biops Market Size (2014-2019)
7.2 Lung Cancer Liquid Biops Key Players in China
7.3 China Lung Cancer Liquid Biops Market Size by Type
7.4 China Lung Cancer Liquid Biops Market Size by Application

8 Japan
8.1 Japan Lung Cancer Liquid Biops Market Size (2014-2019)
8.2 Lung Cancer Liquid Biops Key Players in Japan
8.3 Japan Lung Cancer Liquid Biops Market Size by Type
8.4 Japan Lung Cancer Liquid Biops Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lung Cancer Liquid Biops Market Size (2014-2019)
9.2 Lung Cancer Liquid Biops Key Players in Southeast Asia
9.3 Southeast Asia Lung Cancer Liquid Biops Market Size by Type
9.4 Southeast Asia Lung Cancer Liquid Biops Market Size by Application

10 India
10.1 India Lung Cancer Liquid Biops Market Size (2014-2019)
10.2 Lung Cancer Liquid Biops Key Players in India
10.3 India Lung Cancer Liquid Biops Market Size by Type
10.4 India Lung Cancer Liquid Biops Market Size by Application

11 Central & South America
11.1 Central & South America Lung Cancer Liquid Biops Market Size (2014-2019)
11.2 Lung Cancer Liquid Biops Key Players in Central & South America
11.3 Central & South America Lung Cancer Liquid Biops Market Size by Type
11.4 Central & South America Lung Cancer Liquid Biops Market Size by Application

12 International Players Profiles
12.1 Biocept
12.1.1 Biocept Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lung Cancer Liquid Biops Introduction
12.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.1.5 Biocept Recent Development
12.2 EntroGen
12.2.1 EntroGen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lung Cancer Liquid Biops Introduction
12.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.2.5 EntroGen Recent Development
12.3 Cynvenio Biosystems
12.3.1 Cynvenio Biosystems Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lung Cancer Liquid Biops Introduction
12.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.3.5 Cynvenio Biosystems Recent Development
12.4 Exosome Diagnostics
12.4.1 Exosome Diagnostics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lung Cancer Liquid Biops Introduction
12.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.4.5 Exosome Diagnostics Recent Development
12.5 F. Hoffmann-La Roche
12.5.1 F. Hoffmann-La Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lung Cancer Liquid Biops Introduction
12.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.5.5 F. Hoffmann-La Roche Recent Development
12.6 Clearbridge BioMedics
12.6.1 Clearbridge BioMedics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lung Cancer Liquid Biops Introduction
12.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.6.5 Clearbridge BioMedics Recent Development
12.7 Bio-Rad Laboratories
12.7.1 Bio-Rad Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lung Cancer Liquid Biops Introduction
12.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.7.5 Bio-Rad Laboratories Recent Development
12.8 Agena Bioscience
12.8.1 Agena Bioscience Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lung Cancer Liquid Biops Introduction
12.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.8.5 Agena Bioscience Recent Development
12.9 Cancer Genetics
12.9.1 Cancer Genetics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Lung Cancer Liquid Biops Introduction
12.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.9.5 Cancer Genetics Recent Development
12.10 CellMax Life
12.10.1 CellMax Life Company Details
12.10.2 Company Description and Business Overview
12.10.3 Lung Cancer Liquid Biops Introduction
12.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2014-2019)
12.10.5 CellMax Life Recent Development
12.11 Nateras
12.12 MedGenome
12.13 OncoDNA
12.14 Genomic Health
12.15 Trovagene
12.16 Fluxion Biosciences
12.17 Biodesix
12.18 Epic Sciences
12.19 Shuwen Biotech
12.20 Personal Genome Diagnostics
12.21 Predicine

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Lung Cancer Liquid Biops Key Market Segments
Table Key Players Lung Cancer Liquid Biops Covered
Table Global Lung Cancer Liquid Biops Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lung Cancer Liquid Biops Market Size Market Share by Type 2014-2025
Figure Exosomes and RNA Figures
Table Key Players of Exosomes and RNA
Figure CTCs and ctDNA Figures
Table Key Players of CTCs and ctDNA
Table Global Lung Cancer Liquid Biops Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Physicians'office Laboratories Case Studies
Figure Clinical Diagnostic Laboratories Case Studies
Figure Lung Cancer Liquid Biops Report Years Considered
Table Global Lung Cancer Liquid Biops Market Size 2014-2025 (Million US$)
Figure Global Lung Cancer Liquid Biops Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lung Cancer Liquid Biops Market Size by Regions 2014-2025 (Million US$)
Table Global Lung Cancer Liquid Biops Market Size by Regions 2014-2019 (Million US$)
Table Global Lung Cancer Liquid Biops Market Share by Regions 2014-2019
Figure Global Lung Cancer Liquid Biops Market Share by Regions 2014-2019
Figure Global Lung Cancer Liquid Biops Market Share by Regions 2019
Table Market Top Trends
Table Global Lung Cancer Liquid Biops Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lung Cancer Liquid Biops Market Share by Manufacturers (2014-2019)
Figure Global Lung Cancer Liquid Biops Market Share by Manufacturers in 2018
Table Global Lung Cancer Liquid Biops Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lung Cancer Liquid Biops Product/Solution/Service
Table Date of Enter into Lung Cancer Liquid Biops Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lung Cancer Liquid Biops Market Size by Type (2014-2019) (Million US$)
Table Global Lung Cancer Liquid Biops Market Size Share by Type (2014-2019)
Figure Global Lung Cancer Liquid Biops Market Size Market Share by Type (2014-2019)
Table Global Lung Cancer Liquid Biops Market Size by Application (2014-2019) (Million US$)
Table Global Lung Cancer Liquid Biops Market Size Share by Application (2014-2019)
Figure Global Lung Cancer Liquid Biops Market Size Market Share by Application (2014-2019)
Figure Global Lung Cancer Liquid Biops Revenue Market Share by Application in 2018
Figure United States Lung Cancer Liquid Biops Market Size 2014-2019 (Million US$)
Table United States Key Players Lung Cancer Liquid Biops Revenue (2018-2019) (Million US$)
Table United States Key Players Lung Cancer Liquid Biops Market Share (2018-2019)
Table United States Lung Cancer Liquid Biops Market Size by Type (2014-2019) (Million US$)
Table United States Lung Cancer Liquid Biops Market Share by Type (2014-2019)
Table United States Lung Cancer Liquid Biops Market Size by Application (2014-2019) (Million US$)
Table United States Lung Cancer Liquid Biops Market Share by Application (2014-2019)
Figure Europe Lung Cancer Liquid Biops Market Size 2014-2019 (Million US$)
Table Europe Key Players Lung Cancer Liquid Biops Revenue (2018-2019) (Million US$)
Table Europe Key Players Lung Cancer Liquid Biops Market Share (2018-2019)
Table Europe Lung Cancer Liquid Biops Market Size by Type (2014-2019) (Million US$)
Table Europe Lung Cancer Liquid Biops Market Share by Type (2014-2019)
Table Europe Lung Cancer Liquid Biops Market Size by Application (2014-2019) (Million US$)
Table Europe Lung Cancer Liquid Biops Market Share by Application (2014-2019)
Figure China Lung Cancer Liquid Biops Market Size 2014-2019 (Million US$)
Table China Key Players Lung Cancer Liquid Biops Revenue (2018-2019) (Million US$)
Table China Key Players Lung Cancer Liquid Biops Market Share (2018-2019)
Table China Lung Cancer Liquid Biops Market Size by Type (2014-20189) (Million US$)
Table China Lung Cancer Liquid Biops Market Share by Type (2014-2019)
Table China Lung Cancer Liquid Biops Market Size by Application (2014-2019) (Million US$)
Table China Lung Cancer Liquid Biops Market Share by Application (2014-2019)
Figure Japan Lung Cancer Liquid Biops Market Size 2014-2019 (Million US$)
Table Japan Key Players Lung Cancer Liquid Biops Revenue (2018-2019) (Million US$)
Table Japan Key Players Lung Cancer Liquid Biops Market Share (2018-2019)
Table Japan Lung Cancer Liquid Biops Market Size by Type (2014-2019) (Million US$)
Table Japan Lung Cancer Liquid Biops Market Share by Type (2014-2019)
Table Japan Lung Cancer Liquid Biops Market Size by Application (2014-2019) (Million US$)
Table Japan Lung Cancer Liquid Biops Market Share by Application (2014-2019)
Figure Southeast Asia Lung Cancer Liquid Biops Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lung Cancer Liquid Biops Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lung Cancer Liquid Biops Market Share (2018-2019)
Table Southeast Asia Lung Cancer Liquid Biops Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Liquid Biops Market Share by Type (2014-2019)
Table Southeast Asia Lung Cancer Liquid Biops Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Liquid Biops Market Share by Application (2014-2019)
Figure India Lung Cancer Liquid Biops Market Size 2014-2019 (Million US$)
Table India Key Players Lung Cancer Liquid Biops Revenue (2018-2019) (Million US$)
Table India Key Players Lung Cancer Liquid Biops Market Share (2018-2019)
Table India Lung Cancer Liquid Biops Market Size by Type (2014-2019) (Million US$)
Table India Lung Cancer Liquid Biops Market Share by Type (2014-2019)
Table India Lung Cancer Liquid Biops Market Size by Application (2014-2019) (Million US$)
Table India Lung Cancer Liquid Biops Market Share by Application (2014-2019)
Figure Central & South America Lung Cancer Liquid Biops Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lung Cancer Liquid Biops Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lung Cancer Liquid Biops Market Share (2018-2019)
Table Central & South America Lung Cancer Liquid Biops Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lung Cancer Liquid Biops Market Share by Type (2014-2019)
Table Central & South America Lung Cancer Liquid Biops Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lung Cancer Liquid Biops Market Share by Application (2014-2019)
Table Biocept Company Details
Table Biocept Revenue in Lung Cancer Liquid Biops Business (2014-2019) (Million US$)
Figure Biocept Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table Biocept Recent Development
Table EntroGen Company Details
Table EntroGen Revenue in Lung Cancer Liquid Biops Business (2014-2019)(Million US$)
Figure EntroGen Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table EntroGen Recent Development
Table Cynvenio Biosystems Company Details
Table Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2014-2019)(Million US$)
Figure Cynvenio Biosystems Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table Cynvenio Biosystems Recent Development
Table Exosome Diagnostics Company Details
Table Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2014-2019)(Million US$)
Figure Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table Exosome Diagnostics Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Clearbridge BioMedics Company Details
Table Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2014-2019)(Million US$)
Figure Clearbridge BioMedics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table Clearbridge BioMedics Recent Development
Table Bio-Rad Laboratories Company Details
Table Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2014-2019)(Million US$)
Figure Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table Bio-Rad Laboratories Recent Development
Table Agena Bioscience Company Details
Table Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2014-2019)(Million US$)
Figure Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table Agena Bioscience Recent Development
Table Cancer Genetics Company Details
Table Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2014-2019)(Million US$)
Figure Cancer Genetics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table Cancer Genetics Recent Development
Table CellMax Life Company Details
Table CellMax Life Revenue in Lung Cancer Liquid Biops Business (2014-2019)(Million US$)
Figure CellMax Life Revenue Growth Rate in Lung Cancer Liquid Biops Business (2014-2019)
Table CellMax Life Recent Development
Table Nateras Company Details
Table MedGenome Company Details
Table OncoDNA Company Details
Table Genomic Health Company Details
Table Trovagene Company Details
Table Fluxion Biosciences Company Details
Table Biodesix Company Details
Table Epic Sciences Company Details
Table Shuwen Biotech Company Details
Table Personal Genome Diagnostics Company Details
Table Predicine Company Details
Table Global Lung Cancer Liquid Biops Market Size by Regions (Million US$) 2019-2025
Figure Global Lung Cancer Liquid Biops Market Size Share by Regions (2019-2025)
Figure Global Lung Cancer Liquid Biops Market Size Share by Regions in 2025
Figure United States Lung Cancer Liquid Biops Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lung Cancer Liquid Biops Market Size Forecast (2019-2025)(Million USD)
Figure China Lung Cancer Liquid Biops Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lung Cancer Liquid Biops Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lung Cancer Liquid Biops Market Size Forecast (2019-2025)(Million USD)
Figure India Lung Cancer Liquid Biops Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lung Cancer Liquid Biops Market Size Forecast (2019-2025)(Million USD)
Table Global Lung Cancer Liquid Biops Market Size by Product (2019-2025) (Million US$)
Figure Global Lung Cancer Liquid Biops Market Size by Product (2019-2025)
Figure Global Lung Cancer Liquid Biops Market Size by Product in 2025
Table Global Lung Cancer Liquid Biops Market Size by Application (2019-2025) (Million US$)
Figure Global Lung Cancer Liquid Biops Market Size by Application (2019-2025)
Figure Global Lung Cancer Liquid Biops Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の肺がん市場：市場規模・現状・予測
    Global Lung Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7482 2019年6月14日 96Pages
    当資料は、肺がんのグローバル市場について調査・分析したレポートで、種類別（SCLC肺がん、NSCLC肺がん）、用途別（病院と診療所、がん研究センター、実験室）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の肺がんの診断と治療市場：市場規模・現状・予測
    Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7483 2019年6月14日 103Pages
    当資料は、肺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（非小細胞肺がん、小細胞肺がん）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の肺がんの診断市場：市場規模・現状・予測
    Global Lung Cancer Diagnostics Market Size, Status and Forecast 2019-2025
    QYR9N7484 2019年6月14日 93Pages
    当資料は、肺がんの診断のグローバル市場について調査・分析したレポートで、種類別（イムノアッセイ、フローサイトメトリー、ラピッドテスト、分子アッセイ、ティッシュアレイ、その他）、用途別（工業用、健康管理、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市...
  • 世界の非侵襲がん診断市場：市場規模・現状・予測
    Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2019-2025
    QYR9N7685 2019年6月14日 91Pages
    当資料は、非侵襲がん診断のグローバル市場について調査・分析したレポートで、種類別（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別（血液がん、固形腫瘍、乳がん、肺癌、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界のがん治療薬のパーソナライズ市場：市場規模・現状・予測
    Global Personalizing Cancer Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7800 2019年6月14日 104Pages
    当資料は、がん治療薬のパーソナライズのグローバル市場について調査・分析したレポートで、種類別（免疫療法、ターゲット療法、化学療法、ホルモン療法、その他）、用途別（乳がん、血液がん、消化器がん、前立腺がん、皮膚がん、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の...
  • 世界の非侵襲的がん診断市場：市場規模・現状・予測
    Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2019-2025
    QYR9N7686 2019年6月14日 97Pages
    当資料は、非侵襲的がん診断のグローバル市場について調査・分析したレポートで、種類別（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別（固形腫瘍、血液がん、肺がん、乳がん、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...
  • 世界の上咽頭がん市場：市場規模・現状・予測
    Global Nasopharyngeal Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7629 2019年6月14日 98Pages
    当資料は、上咽頭がんのグローバル市場について調査・分析したレポートで、種類別（手術、放射線、化学療法）、用途別（病院、診療所、がん治療とリハビリセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の黒色腫がん市場：市場規模・現状・予測
    Global Melanoma Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7533 2019年6月14日 96Pages
    当資料は、黒色腫がんのグローバル市場について調査・分析したレポートで、種類別（非侵襲性黒色腫、浸潤性黒色腫）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ...
  • 世界の転移性骨がん市場：市場規模・現状・予測
    Global Metastatic Bones Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7551 2019年6月14日 94Pages
    当資料は、転移性骨がんのグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・転移性骨がんの世界市場規模
    ・主...
  • 世界の腹膜がん市場：市場規模・現状・予測
    Global Peritoneal Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7795 2019年6月14日 93Pages
    当資料は、腹膜がんのグローバル市場について調査・分析したレポートで、種類別（手術、化学療法（抗がん剤）、放射線療法（高エネルギー線））、用途別（がん研究センター、がん病院、手術センター、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...
  • 世界の肺がん市場：市場規模・現状・予測世界の肺がん市場：市場規模・現状・予測 Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…
  • 世界の肺がんの診断と治療市場：市場規模・現状・予測世界の肺がんの診断と治療市場：市場規模・現状・予測 Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the g…
  • 世界の肺がんの診断市場：市場規模・現状・予測世界の肺がんの診断市場：市場規模・現状・予測 Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.As people's awareness of cancer increases and technol…
  • 世界の精密癌診断テスト市場：市場規模・現状・予測世界の精密癌診断テスト市場：市場規模・現状・予測 Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves. In 2018, the global Precision Cancer Diagnostic Tests market size was xx million US$ and it is expected to reach xx milli…
  • 世界の膵がんの診断市場：市場規模・現状・予測世界の膵がんの診断市場：市場規模・現状・予測 Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Bio…